1
Home
Companies

BrainStorm Cell Therapeutics

#10402

Rank

$6.62M

Marketcap

US United States

Country

BrainStorm Cell Therapeutics
Leadership team

Mr. Chaim Lebovits (Chief Exec. Officer)

Dr. Irit Arbel DSc, Ph.D. (Co-Founder & Independent Vice Chair of the Board)

Dr. Ralph Z. Kern (Pres & Chief Medical Officer)

Products/ Services
Biotechnology, Health Care, Medical, Therapeutics
Headquarters
New York, New York, United States
Established
2000
Company Registration
SEC CIK number: 0001137883
Traded as
BCLI
Social Media
URL
https://www.brainstorm-cell.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; and Phase II clinical trial for the treatment of progressive multiple sclerosis and alzheimer's disease, as well as for other neurodegenerative diseases. The company has a partnership with Catalent for manufacturing NurOwn. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.
History

BrainStorm Cell Therapeutics Inc. was founded in August 1999 by scientists from the Weizmann Institute of Science in Rehovot, Israel. The company was initially focused on the research and development of novel technologies for the isolation and cultivation of adult stem cells, with a particular emphasis on CNS applications. In October 2003, the company entered into a collaboration agreement with the University of Massachusetts to develop publicly available patents related to adult mesenchymal stem cell technology for use in clinical trials.

Mission
BrainStorm is dedicated to developing innovative autologous cellular therapies that can improve the quality of life and provide meaningful therapeutic benefit to patients with neurodegenerative diseases.
Vision
To be the pre-eminent provider of secure and effective regenerative medicine to the neuroscience market.
Key Team

Dr. Stacy R. Lindborg Ph.D. (Exec. VP & Chief Devel. Officer)

Dr. Yael Gothelf (VP of Scientific & Regulatory Affairs)

Mr. Uri Yablonka (Exec. VP, Chief Bus. Officer, Sec. & Director)

Ms. Antal Pearl-Lendner (VP & Chief Legal Counsel)

Ms. Alla Patlis CPA, M.B.A. (Controller & Interim CFO)

Dr. Daniel Offen Ph.D. (Chief Scientific Advisor)

Dr. David Setboun M.B.A., Pharm.D. (Exec. VP & COO)

Recognition and Awards
BrainStorm has been the recipient of numerous prestigious awards and recognitions, including the 2009 Red Herring Global 100 Award, the 2011 Regenerative Medicine President’s Award, and the 2010 Frost & Sullivan Global Technology Innovation Award.
References

https://in.investing.com/equities/brainstorm-cell-ther

https://finance.yahoo.com/quote/BCLI/profile?p=BCLI

https://www.crunchbase.com/organization/brainstorm-cell-therapeutics

https://companiesmarketcap.com/

https://www.brainstorm-cell.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

BrainStorm Cell Therapeutics
Leadership team

Mr. Chaim Lebovits (Chief Exec. Officer)

Dr. Irit Arbel DSc, Ph.D. (Co-Founder & Independent Vice Chair of the Board)

Dr. Ralph Z. Kern (Pres & Chief Medical Officer)

Products/ Services
Biotechnology, Health Care, Medical, Therapeutics
Headquarters
New York, New York, United States
Established
2000
Company Registration
SEC CIK number: 0001137883
Traded as
BCLI
Social Media
URL
https://www.brainstorm-cell.com